Correspondence 0001628280-24-048677 from GRI Bio, Inc. (GRI)
GRI Bio, Inc.
Date: Nov. 20, 2024 · CIK: 0001824293 · Accession: 0001628280-24-048677
AI Filing Summary & Sentiment
File numbers found in text: 333-283234
Show Raw Text
CORRESP 1 filename1.htm Document GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA, CA 92037 November 20, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell Re: GRI Bio, Inc. Registration Statement on Form S-3 Filed November 14, 2024 File No. 333-283234 (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, GRI Bio, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, November 22, 2024, at 4:01p.m., Eastern Time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Melanie Ruthrauff Levy or Jason Miller of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 or (858) 314-2140, respectively, with any questions regarding this request. Very truly yours, GRI BIO, INC. /s/ W. Marc Hertz, Ph.D. W. Marc Hertz, Ph.D., Chief Executive Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Adam Lenain, Esq. Melanie Ruthrauff Levy, Esq. Jason Miller, Esq.